Atrial fibrillation

Common Name(s)

Atrial fibrillation

Atrial fibrillation is a condition that occurs when there is an abnormal heart beat that causes poor blood flow to the body. Atrial fibrillation occurs when disorganized signals sent to the heart's upper two chambers, or "atria", cause them to contract quickly and irregularly (fibrillation). When this happens, the upper and lower chambers do not work together as they should. Typical symptoms of atrial fibrillation include decreased blood pressure, weakness, lightheadedness, confusion, and shortness of breath, chest pain and sensation of a racing heart. This condition is often caused by damages to the heart’s structure. A few examples include high blood pressure, heart attacks, previous heart surgery, or lung disease. Factors such as obesity, alcohol intake, high blood pressure, or age may put someone at risk for atrial fibrillation.

There are several tests available to diagnose atrial fibrillation. The most common test is an electrocardiogram (ECG). An ECG records signals as they travel to the heart and can detect abnormal heart rhythms. Atrial fibrillation can be treated if caught early using a procedure to restore the heart's rhythm. Surgery may also be used to restore the heart to a normal rhythm. If atrial fibrillation cannot be converted to a normal heartbeat, medications and other procedures can help control heartbeat. Talk with your doctor to decide which treatment option is best for you. Support groups are also good resources for support and information.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Atrial fibrillation" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Atrial fibrillation" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Atrial fibrillation" returned 6330 free, full-text research articles on human participants. First 3 results:

Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006-2015.
 

Author(s): Lia Alves-Cabratosa, Maria García-Gil, Marc Comas-Cufí, Anna Ponjoan, Ruth Martí-Lluch, Dídac Parramon, Jordi Blanch, Marc Elosua-Bayes, Rafel Ramos

Journal:

 

Hypertension is the most prevalent risk factor for new-onset atrial fibrillation (AF). But few studies have addressed the effect of statins on the incidence of this arrhythmia in patients with hypertension. This study aimed to evaluate the effect of statins on new-onset of this arrhythmia ...

Last Updated: 26 Oct 2017

Go To URL
Is atrial fibrillation a risk factor for normal-tension glaucoma?
 

Author(s): Anna Zaleska-Żmijewska, Maciej Janiszewski, Zbigniew M Wawrzyniak, Marek Kuch, Jerzy Szaflik, Jacek P Szaflik

Journal: Medicine (Baltimore). 2017 Oct;96(43):e8347.

 

Glaucoma (GL) and atrial fibrillation (AF) are diseases of significant social importance. Cardiovascular disorders such as systemic hypertension, hypotension, increased blood viscosity, vasospasm, and diabetes are potential risk factors of GL, especially when intraocular pressure ...

Last Updated: 25 Oct 2017

Go To URL
Mortality prediction using CHADS2/CHA2DS2-VASc/R2CHADS2 scores in systolic heart failure patients with or without atrial fibrillation.
 

Author(s): Yung-Lung Chen, Ching-Lan Cheng, Jin-Long Huang, Ning-I Yang, Heng-Chia Chang, Kuan-Cheng Chang, Shih-Hsien Sung, Kou-Gi Shyu, Chun-Chieh Wang, Wei-Hsian Yin, Jiunn-Lee Lin, Shyh-Ming Chen,

Journal: Medicine (Baltimore). 2017 Oct;96(43):e8338.

 

The CHADS2, CHA2DS2-VASc, and R2CHADS2 scores are well-known predictors of stroke caused by atrial fibrillation (AF), but no studies have evaluated their use for stratifying all-cause mortality risk in patients discharged for systolic heart failure (SHF) with or without AF.This study ...

Last Updated: 25 Oct 2017

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Atrial fibrillation" returned 893 free, full-text review articles on human participants. First 3 results:

Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.
 

Author(s): Xiaoxuan Gong, Shaowen Tang, Jiangjin Li, Xiwen Zhang, Xiaoyi Tian, Shuren Ma

Journal:

 

The aim of this systematic review and network meta-analysis was to evaluate the comparative efficacy and safety of antiplatelet agents, vitamin K antagonist (VKA) and non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI).

Last Updated: 12 Oct 2017

Go To URL
Comparison of Empiric Isolation and Conventional Isolation of Superior Vena Cava in Addition to Pulmonary Vein Isolation on the Outcome of Paroxysmal Atrial Fibrillation Ablation.
 

Author(s): Jin-Yi Li, Jing-Bo Jiang, Guo-Qiang Zhong, Hong-Hong Ke, Yan He

Journal: Int Heart J. 2017 Aug;58(4):500-505.

 

Radiofrequency catheter ablation (RFCA) in the treatment of AF is currently based on pulmonary vein isolation (PVI). Some studies have investigated the efficacy of empiric SVC isolation (SVCI) in addition to conventional PVI in order to improve success rates and reduce recurrence ...

Last Updated: 10 Jul 2017

Go To URL
Association between KCNE1 G38S gene polymorphism and risk of atrial fibrillation: A PRISMA-compliant meta-analysis.
 

Author(s): Yu-Feng Jiang, Min Chen, Nan-Nan Zhang, Hua-Jia Yang, Lang-Biao Xu, Qing Rui, Si-Jia Sun, Jia-Lu Yao, Ya-Feng Zhou

Journal: Medicine (Baltimore). 2017 Jun;96(25):e7253.

 

Previous case-control studies on association between KCNE1 G38S polymorphism and risk of atrial fibrillation (AF) have been published but because of the conflicting results and small sample size of individual studies, the consolidated result is still controversial.

Last Updated: 22 Jun 2017

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Subclinical Postoperative Atrial Fibrillation
 

Status: Recruiting

Condition Summary: Atrial Fibrillation

 

Last Updated: 18 Oct 2017

Go to URL
Exercise Training in Patients With Atrial Fibrillation (OPPORTUNITY Study)
 

Status: Recruiting

Condition Summary: Atrial Fibrillation

 

Last Updated: 19 Jun 2017

Go to URL

Last Updated: 7 Apr 2017

Go to URL